Skip to main content
Fig. 4 | BMC Pulmonary Medicine

Fig. 4

From: Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative

Fig. 4

OS in patients diagnosed with stage IIIB–IV NSCLC in 2015–2016 by histology and receipt of SACT. OS overall survival, NSCLC non-small cell lung cancer, SACT systemic anti-cancer therapy, CI confidence interval, IQR interquartile range, NSQ non-squamous cell carcinoma, SQ squamous cell carcinoma

Back to article page